Oxcarbazepine Tablet, Film Coated
Product Images NDC 63629-9186

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 63629-9186). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636299186)

Label for Oxcarbazepine Tablets, USP, 300 mg film-coated tablets by Bryant Ranch Prepack. The label includes dosage strength, NDC 63629-9186-01, and instructions for storage, color additive information (FD&C Yellow No. 5 tartrazine), and dispensing guidelines. Package contains 500 tablets for oral use, Rx only.*

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

Chemical structure of oxcarbazepine, showing its bicyclic ring system with ketone and amide functional groups as depicted in the image.*

FDA Label Image

Figure 1 (Oxcarbazepine 02)

A Kaplan-Meier survival curve chart depicting exit rates over time from day 2 to day 11 of a trial. The chart compares two treatment groups: Oxcarbazepine (solid line) and Placebo (dotted line). The y-axis shows exit rates from 0.0 to 1.0, while the x-axis shows time on trial in days. A log-rank test with p-value=0.0001 is indicated, showing statistical comparison between the groups.*

FDA Label Image

Figure 2 (Oxcarbazepine 03)

A line graph illustrating seizure rate over days from first dose to first seizure comparing treatment with Oxcarbazepine versus Placebo. The x-axis represents days from first dose to first seizure (0 to 140), and the y-axis shows seizure rate (0 to 1.0). The graph includes a log-rank test p-value of 0.046.*

FDA Label Image

Figure 3 (Oxcarbazepine 04)

A Kaplan-Meier plot showing exit rate over time (days) for two treatment groups labeled HIGH (solid line) and LOW (dotted line). The x-axis represents time to exit in days up to 130 days; the y-axis shows exit rate from 0 to 1. The plot includes a log-rank test with p-value=0.0001 indicating statistical comparison between groups.*

FDA Label Image

Figure 4 (Oxcarbazepine 05)

A Kaplan-Meier curve showing exit rates over time in days for two treatment groups labeled HIGH and LOW. The x-axis represents time to exit in days, and the y-axis represents exit rate from 0 to 1. The LOW group shows a faster increase in exit rate compared to the HIGH group. The graph includes a log-rank test p-value of 0.0001 indicating statistical significance between groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.